E8TN.F 24.35 (-1.81%)
FR0013240934Medical Diagnostics & ResearchDiagnostics & Research

Eurobio Scientific (E8TN.F) Competitor Comparison

We are evaluating the key criteria listed to compare Eurobio Scientific (E8TN.F) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - E8TN.F ranking 0 / 58

These are the competitors of Eurobio Scientific in the industry Diagnostics & Research ranked by linearity 3 years
1. Laboratory Corp of America Holdings LH
373.43
2. Sera Prognostics SERA
41.7
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Twist Bioscience TWST
27.97
5. Thermo Fisher Scientific TMO
20.55
6. Agilent Technologies A
18.89
7. Anixa Biosciences ANIX
18.46
8. PerkinElmer PKI
16.14
9. Waters WAT
15.3
10. Mettler-Toledo MTD
14.9
11. IQVIA Holdings IQV
12.15
12. Danaher DHR
11.84
13. Qiagen QGEN
11.73
14. Quest Diagnostics DGX
11.33
15. Syneos Health SYNH
10.68
16. Icon ICLR
10.19
17. IDEXX Laboratories IDXX
8.83
18. Heska HSKA
7.67
19. Exact Sciences EXAS
6.71
20. Olink Holding OLK
6.67
21. Guardant Health GH
6.25
22. DexCom DXCM
5.43
23. Charles River Laboratories CRL
4.83
24. Bioventus BVS
4.74
25. NeoGenomics NEO
4.58
26. Global Cord Blood CO
4.22
27. Sotera Health SHC
4.05
28. National Research NRC
3.92
29. Myriad Genetics MYGN
3.66
30. MaxCyte MXCT
3.31
31. CareDx CDNA
2.78
32. Psychemedics PMD
2.62
33. Pacific Biosciences of California PACB
2.61
34. Neogen NEOG
2.58
35. Enzo Biochem ENZ
2.57
36. Biodesix BDSX
2.46
37. Fulgent Genetics FLGT
2.45
38. Personalis PSNL
2.44
39. Exagen XGN
2.4
40. Illumina ILMN
2.36
41. MDxHealth MDXH
2.3
42. Medpace Holdings MEDP
2.27
43. Precipio PRPO
2.26
44. Lantheus Holdings LNTH
2.23
45. Trinity Biotech TRIB
2
46. Neuronetics STIM
1.98
47. RadNet RDNT
1.82
48. DarioHealth DRIO
1.79
49. Organovo Holdings ONVO
1.79
50. Inotiv NOTV
1.73
51. Co-Diagnostics CODX
1.7
52. Interpace Biosciences IDXG
1.68
53. bioAffinity Technologies BIAF
1.55
54. SeqLL SQL
1.48
55. Prenetics Global PRE
1.42
56. Aspira Womens Health AWH
1.38
57. Meridian Bioscience VIVO
0.73
58. Natera NTRA
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.